Spencer Lazar has left venture-capital firm General Catalyst, where he was a partner, to join Lemonade Insurance Co.
Read more here.
![[Insightec in Asian Hospital and Healthcare Management] Insightec announces FDA approval of Exablate Neuro for the treatment of Parkinson’s Disease](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Insightec in Asian Hospital and Healthcare Management] Insightec announces FDA approval of Exablate Neuro for the treatment of Parkinson’s Disease
November 5, 2021
[Highcon in Printing Impressions] Highcon Announces 40% Increase in Speed for Euclid Finishing Systems
June 7, 2017
